Abstract: The present disclosure provides a cosmetic composition comprising micelle encapsulated oxyresveratrol, whereby in said composition, oxyresveratrol is stabilized and is tolerant to thermal and oxidative degradation upon storage.
Claims:1. A cosmetically acceptable composition for skin-lightening comprising:
a. diethylhexyl syringlydine malonate;
b. citric acid;
c. micelle encapsulated oxyresveratrol, and
d. a cosmetically acceptable ingredient,
wherein diethylhexyl syringlydine malonate weight percentage in said composition is in the range of 0.1-0.5%, citric acid weight percentage in said composition is in the range of 0.2-0.4%, and micelle encapsulated oxyresveratrol weight percentage in said composition is in the range of 0.1-1%.
2. The composition as claimed in claim 1, wherein diethylhexyl syringlydine malonate weight percentage in said composition is 0.3%, citric acid percentage in said composition is 0.3%, and micelle encapsulated oxyresveratrol weight percentage in said composition is 1%.
3. The composition as claimed in claim 1, wherein said cosmetically acceptable ingredient is:
a. disodium EDTA having weight percentage in the range of 0.01-0.3%;
b. glycerin having weight percentage in the range of 1-5%;
c. propylene glycol having weight percentage in the range of 1-5%;
d. acrylates/C10-30 alkyl acrylate crosspolymer having weight percentage in the range of 0.1-0.4%;
e. steareth -21 having weight percentage in the range of 1-3%;
f. steareth-2 having weight percentage in the range of 0.5-1.5%;
g. isopropyl palmitate having weight percentage in the range of 0.5-5%;
h. isohexadecane having weight percentage in the range of 0.5%-5%;
i. glyceryl stearate having weight percentage in the range of 0.25-2%;
j. mineral oil having weight percentagein the range of 2-10%;
k. ethylhexyl methoxycinnamate having weight percentagein the range of 3-9%;
l. cetyl alcohol having weight percentage in the range of 0.5-2%;
m. glycol distearate having weight percentage in the range of 0.25-2%;
n. methyl paraben having weight percentage in the range of 0.01-0.3%;
o. propyl paraben having weight percentage in the range of 0.01-0.1%;
p. triethanolamine having weight percentage in the range of 0.1-0.5%;
q. pheneoxyethanol having weight percentage in the range of 0.1-0.7%; and
r. cyclopentasiloxane, dimethiconol, dimethicone crosspolymer & phenyltrimethicone blend having weight percentage in the range of 0.5-5%.
4. The composition as claimed in claim 1, comprising:
a. disodium EDTA having weight percentage of 0.05%;
b. glycerin having weight percentage of 2.86%;
c. propylene glycol having weight percentage of 2%;
d. acrylates/C10-30 alkyl acrylate crosspolymer having weight percentage of 0.25%;
e. steareth -21 having weight percentage of 1.2%;
f. steareth-2 having weight percentage of 0.6%;
g. isopropyl palmitate having weight percentage of 1%;
h. isohexadecane having weight percentage 1%;
i. glyceryl stearate having weight percentage 0.5%;
j. mineral oil having weight percentage of 4%;
k. ethylhexyl methoxycinnamate having weight percentage of 6%;
l. cetyl alcohol having weight percentage of 1%;
m. glycol distearate having weight percentage of 1%;
n. methyl paraben having weight percentage 0.1%;
o. propyl paraben having weight percentage of 0.03%;
p. triethanolamine having weight percentage of 0.35%;
q. pheneoxyethanol having weight percentage 0.5%;
r. cyclopentasiloxane, dimethiconol, dimethicone crosspolymer & phenyltrimethicone blend having weight percentage of 1.42%;
s. diethylhexyl syringlydine malonate weight percentage of 0.3%;
t. citric acid weight percentage of 0.3%;
u. micelle encapsulated oxyresveratrol weight percentage of 1%; and
v. water to make up to 100%.
5. The composition as claimed in claim 1, wherein said micelle encapsulated oxyresveratrol weight percentage in said composition recoverable after 2 weeks at a temperature in the range of 5-50oC is in the range of 94-100%.
6. A method of preparing a composition as claimed in claim 4, comprising the steps of:
a. contacting water, disodium EDTA, glycerin, propylene glycol, and acrylates/C10-C30 alkyl acrylate crosspolymer at a temperature in the range of 75-80°C to obtain a mix A;
b. contacting steareth-21, steareth-2, isopropyl palmitate, isohexadecane, glyceryl stearate, mineral oil, ethylhexylmethoxycinnamate, cetyl alcohol, glycol distearate, and diethylhexyl syringlydine malonate at a temperature in the range of 75-80°C to obtain a mix B;
c. contacting mix A and mic B to obtain an evenly dispersed mix C, and adjusting the temperature to 38-42°C;
d. contacting triethanolamine with mix C to obtain a mix D;
e. contacting citric acid to mix D to obtain a mix E;
f. contacting micelle encapsulated oxyresveratrol with mix E to obtain a mix F;
g. contacting cyclopentasiloxane dimethiconol, dimethicone crosspolymer & phenyltrimethicone blend to mix F to obtain a mix G; and
h. contacting phenoxyethanol, methylparaben, and propylparaben to mix G in a sequential order to obtain a composition.
7. A method of stabilizing micelle encapsulated oxyresveratrol, said method comprising:
a. obtaining micelle encapsulated oxyresveratrol;
b. obtaining citric acid;
c. obtaining diethylhexyl syringlydine malonate; and
d. contacting micelle encapsulated oxyresveratrol, citric acid, and diethylhexyl syringlydine malonate to obtain a mixture, wherein micelle encapsulated oxyresveratrol in said mixture is stabilized.
8. The method as claimed in claim 7, wherein diethylhexyl syringlydine malonate weight percentage is in the range of 0.1-0.5%, citric acid weight percentage is in the range of 0.2-0.4%, and micelle encapsulated oxyresveratrol weight percentage is in the range of 0.1-1%.
Dated this September 2016
, Description:As Attached
| # | Name | Date |
|---|---|---|
| 1 | Correspondence by Agent_Form26_14-12-2016.pdf | 2016-12-14 |
| 1 | Form 5 [03-10-2016(online)].pdf | 2016-10-03 |
| 2 | Form 26 [07-12-2016(online)].pdf | 2016-12-07 |
| 2 | Form 3 [03-10-2016(online)].pdf | 2016-10-03 |
| 3 | Drawing [03-10-2016(online)].pdf | 2016-10-03 |
| 3 | Other Patent Document [07-12-2016(online)].pdf | 2016-12-07 |
| 4 | Description(Complete) [03-10-2016(online)].pdf | 2016-10-03 |
| 5 | Drawing [03-10-2016(online)].pdf | 2016-10-03 |
| 5 | Other Patent Document [07-12-2016(online)].pdf | 2016-12-07 |
| 6 | Form 26 [07-12-2016(online)].pdf | 2016-12-07 |
| 6 | Form 3 [03-10-2016(online)].pdf | 2016-10-03 |
| 7 | Correspondence by Agent_Form26_14-12-2016.pdf | 2016-12-14 |
| 7 | Form 5 [03-10-2016(online)].pdf | 2016-10-03 |